This inventor holds 1 USPTO granted patent. Top assignee: Genaissance Pharmaceuticals, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovations of Alison E Anastasio
Introduction
Alison E Anastasio is a notable inventor based in New Haven, CT (US). She has made significant contributions to the field of genetics, particularly through her work on the Angiotensin Receptor 1 (AGTR1) gene. Her innovative research has led to the development of novel genetic variants that have implications for understanding various health conditions.
Latest Patents
Anastasio holds a patent for her work titled "Haplotypes of the AGTR1 gene." This patent describes various genotypes, haplotypes, and haplotype pairs that exist in the general United States population for the AGTR1 gene. The patent also discloses compositions and methods for haplotyping and/or genotyping the AGTR1 gene in individuals. Additionally, polynucleotides defined by the sequence of the haplotypes disclosed in her patent are described. She has 1 patent to her name.
Career Highlights
Alison E Anastasio is associated with Genaissance Pharmaceuticals, Inc., where she continues to advance her research in genetics. Her work has been instrumental in enhancing the understanding of genetic variations and their potential impacts on health.
Collaborations
Anastasio has collaborated with notable colleagues, including Kevin Finkel and Beena Koshy, to further her research endeavors. Their combined expertise has contributed to the success of her projects.
Conclusion
Alison E Anastasio's contributions to genetic research, particularly through her patent on the AGTR1 gene, highlight her role as an innovative inventor in the field. Her work continues to pave the way for advancements in genetic understanding and applications.